GenSight - Articles and news items

Promising Phase I/II results for GenSight’s GS010 in LHON

Industry news / 9 June 2016 / Victoria White, Digital Content Producer

The Phase I/II study was designed to demonstrate the safety and tolerability of GS010 in 15 patients with Leber’s Hereditary Optic Neuropathy…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+